Annual CFO
-$34.55 M
-$7.59 M-28.17%
01 December 2023
Summary:
OnKure Therapeutics annual cash flow from operations is currently -$34.55 million, with the most recent change of -$7.59 million (-28.17%) on 01 December 2023.OKUR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$13.00 M
-$6.53 M-100.83%
30 September 2024
Summary:
OnKure Therapeutics quarterly cash flow from operations is currently -$13.00 million, with the most recent change of -$6.53 million (-100.83%) on 30 September 2024. Over the past year, it has increased by +$15.28 million (+54.04%).OKUR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$20.72 M
+$15.28 M+42.45%
30 September 2024
Summary:
OnKure Therapeutics TTM cash flow from operations is currently -$20.72 million, with the most recent change of +$15.28 million (+42.45%) on 30 September 2024. Over the past year, it has increased by +$23.21 million (+52.84%).OKUR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OKUR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.2% | +54.0% | +52.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
OKUR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +28.2% | -238.5% | +355.1% |
OnKure Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.00 M(+100.8%) | -$20.72 M(-42.5%) |
| June 2024 | - | -$6.47 M(-39.1%) | -$36.00 M(-11.4%) |
| Mar 2024 | - | -$10.63 M(-213.3%) | -$40.62 M(+17.6%) |
| Dec 2023 | - | $9.38 M | -$34.55 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$34.55 M(+28.2%) | - | - |
| Sept 2023 | - | -$28.28 M(+155.0%) | -$43.93 M(+180.8%) |
| June 2023 | - | -$11.09 M(+143.6%) | -$15.65 M(+243.6%) |
| Mar 2023 | - | -$4.55 M | -$4.55 M |
| Dec 2022 | -$26.95 M | - | - |
FAQ
- What is OnKure Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for OnKure Therapeutics?
- What is OnKure Therapeutics annual CFO year-on-year change?
- What is OnKure Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for OnKure Therapeutics?
- What is OnKure Therapeutics quarterly CFO year-on-year change?
- What is OnKure Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for OnKure Therapeutics?
- What is OnKure Therapeutics TTM CFO year-on-year change?
What is OnKure Therapeutics annual cash flow from operations?
The current annual CFO of OKUR is -$34.55 M
What is the all time high annual CFO for OnKure Therapeutics?
OnKure Therapeutics all-time high annual cash flow from operations is -$26.95 M
What is OnKure Therapeutics annual CFO year-on-year change?
Over the past year, OKUR annual cash flow from operations has changed by -$7.59 M (-28.17%)
What is OnKure Therapeutics quarterly cash flow from operations?
The current quarterly CFO of OKUR is -$13.00 M
What is the all time high quarterly CFO for OnKure Therapeutics?
OnKure Therapeutics all-time high quarterly cash flow from operations is $9.38 M
What is OnKure Therapeutics quarterly CFO year-on-year change?
Over the past year, OKUR quarterly cash flow from operations has changed by +$15.28 M (+54.04%)
What is OnKure Therapeutics TTM cash flow from operations?
The current TTM CFO of OKUR is -$20.72 M
What is the all time high TTM CFO for OnKure Therapeutics?
OnKure Therapeutics all-time high TTM cash flow from operations is -$4.55 M
What is OnKure Therapeutics TTM CFO year-on-year change?
Over the past year, OKUR TTM cash flow from operations has changed by +$23.21 M (+52.84%)